UnitedHealthcare Will Drop Prior Authorization on 1,700 Codes Starting October 1

UnitedHealthcare announced Tuesday, September 1, that it's removing prior authorization requirements from roughly 1,700 service codes, effective October 1, according to Fierce Healthcare and Quartz. The cuts span commercial plans, Affordable Care Act coverage, Medicare Advantage, and Medicaid, touching cardiology, genetic and lab testing, durable medical equipment, chiropractic care, physical and occupational therapy, orthopedic procedures, and home health services.

The breakdown, per healthcaredive: more than 800 codes for commercial plans, about 940 for ACA plans, roughly 120 for Medicare Advantage and dual special needs plans. Medicaid cuts vary wildly by state, from three codes in Washington, D.C. to more than 600 in Texas. UnitedHealthcare's Oxford plans, sold mostly in New York, New Jersey, and Connecticut, will see 1,400 codes lose the prior auth requirement.

This is a follow-through on a commitment UnitedHealthcare made in May to eliminate 30% of its prior authorizations by the end of 2026. CEO Tim Noel said in May the changes are meant to make it "easier for patients to get the care they need when they need it" while letting doctors "spend more time with their patients." He also said prior authorization "is an essential safeguard but should only be used when it truly protects patients and improves care."

The skepticism starts with the math.

UnitedHealthcare itself says prior authorization only applies to about 2% of total claims, and the company approves roughly 92% of those requests, according to Quartz. Cutting 30% of that 2% doesn't move the needle much.

Wendell Potter, a former vice president of corporate communications at a major health insurer and a current proponent of single-payer healthcare, put it bluntly in comments to MedPage Today. "A lot of what's on the list is low-stakes: minor skin lesion excisions, routine injections, hearing-aid accessory codes, prosthetic components, and notably a large number of 'unlisted procedure' placeholder codes that are rarely billed at all," Potter said. "Removing prior authorization from codes nobody uses generates a big number at no real cost to UHC."

Potter said what's missing matters more. "Specialty pharmacy/injectable drugs, GLP-1s, most oncology drug regimens, and most cardiac device implants are the categories that actually drive the PA controversy and cost exposure." By his estimate, the change amounts to roughly 0.6 percentage points of UHC's total claims volume shifting off prior authorization.

Michael Baker, director of healthcare policy at the right-leaning American Action Forum, offered a similar read from the other side of the aisle. He called the move "a potentially meaningful step in rethinking PA" given the insurer's size, but cautioned that "eliminating PA does not necessarily mean unconditional coverage." Baker also flagged that UnitedHealthcare "has also not disclosed how many actual authorization requests, patients, or dollars of spending those codes represent, making the 1,700 figure a somewhat imprecise measure of the change."

Without knowing how many actual claims or dollars those 1,700 codes touch, the number is a headline rather than a measurement. UnitedHealthcare has not published that data.

Context: a reckoning that started with a murder

This effort traces back to the killing of UnitedHealthcare CEO Brian Thompson in December 2024, an event healthcaredive describes as a "flashpoint" that forced insurers into a broader reckoning over how they handle care denials and prior authorization. Since then, insurers have faced pressure from the Trump administration, CMS rule changes, and public anger to trim back what doctors call unnecessary red tape.

UnitedHealth signed onto an industry-wide prior authorization reform pledge alongside other major carriers. According to an AHIP and Blue Cross Blue Shield Association update cited by Fierce Healthcare, plans have collectively reduced prior authorizations by 11% under that pledge, and CMS says 6.5 million reviews have been eliminated industry-wide since the effort began in 2025.

But a KFF analysis cited by both Fierce Healthcare and Quartz found that denial rates for prior authorization requests last year still ranged from 12% to 18% among people on Medicare Advantage, Medicaid, or ACA individual coverage. That's the gap between insurers touting fewer reviews and patients still getting turned down at similar rates.

Notably, benefitspro framed the announcement differently than other outlets, describing the change as part of insurer efforts "to ward off new federal rules" rather than primarily a patient-care initiative. No other source in this reporting corroborates that specific framing with an on-record UnitedHealthcare statement, so it should be read as one outlet's interpretation, not an established fact.

UnitedHealthcare also announced a rural prior authorization waiver program launching November 1 for eligible rural hospitals, and said it's speeding up payments by as much as 50% for roughly 1,400 rural and Critical Access Hospitals during the third quarter, according to Quartz.

The October 1 effective date is close. Providers and billing teams are already being told to map the new code lists against their own contracts, since UnitedHealthcare has not published the full set of affected codes across every plan type, according to RevCycle Intelligence. Whether this translates into fewer actual care delays for patients, or whether the real cost drivers Potter flagged—GLP-1s, oncology drugs, cardiac devices—ever make it onto a future list remains an open question UnitedHealthcare has not answered.